Effect of Long-Chain ω-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial -

Effect of Long-Chain ω-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
Information type: Randomised controlled trials
Source: JAMA Internal Medicine
Specialities: Cardiovascular system disorders
Summary
Daily supplementation with long-chain ω-3 PUFAs (DHA and EPA) or macular xanthophylls (lutein and zeaxanthin), in addition to minerals and vitamins, did not reduce the risk of CVD (myocardial infarction, stroke, or cardiovascular death) in elderly patients (median 74yr) with AMD.
UKMi comment
A Commentary on this research is available via the link below.
Related links: Commentary